• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与年龄、性别匹配的健康对照组、控制性高血压组以及在 APPROPRIATE 试验的扩展阶段接受普萘洛尔治疗的患者相比,耐药性高血压患者的血清反应性氮物种水平较高,总抗氧化能力较低。

High serum levels of reactive nitrogen species and low total antioxidant capacity in patients with resistant hypertension compared to those in age- gender matched healthy controls, controlled hypertension and follow up with propranolol treatment in the extended APPROPRIATE trial.

机构信息

Department of Clinical Medicine, Faculty of Medicine, University of Colombo, Colombo, Sri Lanka.

Institute of Biochemistry, Molecular Biology & Biotechnology, University of Colombo, Colombo, Sri Lanka.

出版信息

BMC Res Notes. 2024 Aug 13;17(1):223. doi: 10.1186/s13104-024-06884-8.

DOI:10.1186/s13104-024-06884-8
PMID:39138542
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11323664/
Abstract

OBJECTIVES

To perform a comparative analysis of the extended APPROPRIATE trial of measures of reactive nitrogen species and antioxidant capacity in patients having resistant hypertension with controlled hypertension and healthy controls.

RESULTS

Mean serum NO- and NOx levels were significantly lower and mean AOC was significantly higher in patients with controlled hypertension (n = 38) and healthy controls (n = 38) compared to resistant hypertension (RHTN) patients (n = 40) at the pre-intervention stage (p < 0.001). The serum NO-, NOx and AOC levels of both controlled hypertension and healthy controls were comparable to those of the RHTN patients following treatment with propranolol (n = 18). Considering all samples (n = 114) we noted that there were significant weak and moderate positive correlations between NO levels with systolic blood pressure (SBP) and diastolic blood pressure (DBP) (r = 0.396, p < 0.001 and r = 0.292, p = 0.004) as well as total NOx levels with SBP and DBP (r = 0.636 and r = 0.480 respectively, p < 0.001). Conversely, there was a significant negative correlation between AOC levels with SBP and DBP (r= -0.846 and r = -0.626 respectively, p < 0.001).

摘要

目的

对 APPROPRIATE 试验中抗高血压治疗前后患者反应性氮物种和抗氧化能力的测量结果进行比较分析,以评估抗高血压治疗的效果。

结果

与难治性高血压患者相比,接受抗高血压治疗的患者(n=38)和健康对照组(n=38)的血清 NO-和 NOx 水平明显降低,AOC 水平明显升高(p<0.001)。经过普萘洛尔治疗后,控制高血压和健康对照组的血清 NO-、NOx 和 AOC 水平与难治性高血压患者相当(n=18)。考虑到所有样本(n=114),我们发现 NO 水平与收缩压(SBP)和舒张压(DBP)之间存在显著的弱正相关和中度正相关(r=0.396,p<0.001 和 r=0.292,p=0.004),总 NOx 水平与 SBP 和 DBP 之间也存在显著的强正相关(r=0.636 和 r=0.480,p<0.001)。相反,AOC 水平与 SBP 和 DBP 之间存在显著的负相关(r=-0.846 和 r=-0.626,p<0.001)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bfa/11323664/5b36e559cea5/13104_2024_6884_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bfa/11323664/bf85025213b6/13104_2024_6884_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bfa/11323664/41e765435d46/13104_2024_6884_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bfa/11323664/5b36e559cea5/13104_2024_6884_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bfa/11323664/bf85025213b6/13104_2024_6884_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bfa/11323664/41e765435d46/13104_2024_6884_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bfa/11323664/5b36e559cea5/13104_2024_6884_Fig4_HTML.jpg

相似文献

1
High serum levels of reactive nitrogen species and low total antioxidant capacity in patients with resistant hypertension compared to those in age- gender matched healthy controls, controlled hypertension and follow up with propranolol treatment in the extended APPROPRIATE trial.与年龄、性别匹配的健康对照组、控制性高血压组以及在 APPROPRIATE 试验的扩展阶段接受普萘洛尔治疗的患者相比,耐药性高血压患者的血清反应性氮物种水平较高,总抗氧化能力较低。
BMC Res Notes. 2024 Aug 13;17(1):223. doi: 10.1186/s13104-024-06884-8.
2
The impact of propranolol on nitric oxide and total antioxidant capacity in patients with resistant hypertension-evidence from the APPROPRIATE trial.普萘洛尔对耐药性高血压患者一氧化氮和总抗氧化能力的影响——来自 APPROPRIATE 试验的证据。
BMC Res Notes. 2020 Apr 21;13(1):228. doi: 10.1186/s13104-020-05067-5.
3
Addition of Propranolol in Resistant Arterial hypertension Treatment (APROPRIATE study): study protocol for a randomized double-blind placebo-controlled trial.普萘洛尔用于难治性动脉高血压治疗的添加治疗(APROPRIATE研究):一项随机双盲安慰剂对照试验的研究方案
Trials. 2017 Mar 14;18(1):124. doi: 10.1186/s13063-017-1863-1.
4
High-circulating leptin levels are associated with increased blood pressure in uncontrolled resistant hypertension.高循环瘦素水平与未控制的耐药性高血压中的血压升高有关。
J Hum Hypertens. 2013 Apr;27(4):225-30. doi: 10.1038/jhh.2012.29. Epub 2012 Jul 19.
5
Pharmacotherapy for hypertension in adults aged 18 to 59 years.18至59岁成年人高血压的药物治疗
Cochrane Database Syst Rev. 2017 Aug 16;8(8):CD008276. doi: 10.1002/14651858.CD008276.pub2.
6
Comparative study of the efficacy and tolerability of hydroflumethiazide versus propranolol in Africans with mild to moderate hypertension.
East Afr Med J. 1993 May;70(5):277-9.
7
Achieved diastolic blood pressure and pulse pressure at target systolic blood pressure (120-140 mmHg) and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials.在高危患者中实现了目标收缩压(120-140mmHg)下的舒张压和脉压,并取得了心血管结局:ONTARGET 和 TRANSCEND 试验的结果。
Eur Heart J. 2018 Sep 1;39(33):3105-3114. doi: 10.1093/eurheartj/ehy287.
8
Efficacy and tolerability of nebivolol monotherapy by baseline systolic blood pressure: a retrospective analysis of pooled data from two multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group, dose-ranging studies in patients with mild to moderate essential hypertension.根据基线收缩压评估比索洛尔单药治疗的疗效和耐受性:两项多中心、12 周、随机、双盲、安慰剂对照、平行分组、剂量范围研究的汇总数据的回顾性分析,这些研究纳入了轻至中度原发性高血压患者。
Clin Ther. 2009 Sep;31(9):1946-56. doi: 10.1016/j.clinthera.2009.08.028.
9
Comparison of a lifestyle modification program with propranolol use in the management of diastolic hypertension.生活方式改善计划与使用普萘洛尔治疗舒张期高血压的比较。
J Gen Intern Med. 1995 Aug;10(8):419-28. doi: 10.1007/BF02599912.
10
Blood pressure reactivity in the evaluation of resting blood pressure and mood responses to pindolol and propranolol in hypertensive patients.高血压患者静息血压评估中的血压反应性以及对吲哚洛尔和普萘洛尔的情绪反应
Heart Lung. 1993 Sep-Oct;22(5):383-91.

本文引用的文献

1
2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA).2023ESH 动脉高血压管理指南 欧洲高血压学会动脉高血压管理工作组:得到国际高血压学会 (ISH) 和欧洲肾脏协会 (ERA) 的认可。
J Hypertens. 2023 Dec 1;41(12):1874-2071. doi: 10.1097/HJH.0000000000003480. Epub 2023 Sep 26.
2
Oxidative Stress, Antioxidants and Hypertension.氧化应激、抗氧化剂与高血压
Antioxidants (Basel). 2023 Jan 27;12(2):281. doi: 10.3390/antiox12020281.
3
Nitric Oxide as a Central Molecule in Hypertension: Focus on the Vasorelaxant Activity of New Nitric Oxide Donors.
一氧化氮作为高血压的核心分子:聚焦新型一氧化氮供体的血管舒张活性
Biology (Basel). 2021 Oct 14;10(10):1041. doi: 10.3390/biology10101041.
4
The impact of propranolol on nitric oxide and total antioxidant capacity in patients with resistant hypertension-evidence from the APPROPRIATE trial.普萘洛尔对耐药性高血压患者一氧化氮和总抗氧化能力的影响——来自 APPROPRIATE 试验的证据。
BMC Res Notes. 2020 Apr 21;13(1):228. doi: 10.1186/s13104-020-05067-5.
5
Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association.耐药性高血压:检测、评估与管理:美国心脏协会科学声明。
Hypertension. 2018 Nov;72(5):e53-e90. doi: 10.1161/HYP.0000000000000084.
6
Univariate Outliers: A Conceptual Overview for the Nurse Researcher.单变量离群值:护理研究者的概念性概述
Can J Nurs Res. 2019 Mar;51(1):31-37. doi: 10.1177/0844562118786647. Epub 2018 Jul 3.
7
Tempol, a superoxide dismutase-mimetic drug, prevents chronic ischemic renal injury in two-kidney, one-clip hypertensive rats.替普瑞酮,一种超氧化物歧化酶模拟药物,可预防两肾一夹型高血压大鼠的慢性缺血性肾损伤。
Clin Exp Hypertens. 2018;40(8):721-729. doi: 10.1080/10641963.2018.1425423. Epub 2018 Jan 23.
8
Cardioprotective Angiotensin-(1-7) Peptide Acts as a Natural-Biased Ligand at the Angiotensin II Type 1 Receptor.具有心脏保护作用的血管紧张素 -(1 - 7)肽作为血管紧张素II 1型受体的天然偏向性配体发挥作用。
Hypertension. 2016 Dec;68(6):1365-1374. doi: 10.1161/HYPERTENSIONAHA.116.08118. Epub 2016 Oct 3.
9
Reactive oxygen species, vascular Noxs, and hypertension: focus on translational and clinical research.活性氧、血管 Nox 与高血压:聚焦转化与临床研究。
Antioxid Redox Signal. 2014 Jan 1;20(1):164-82. doi: 10.1089/ars.2013.5302. Epub 2013 Jun 6.
10
The role of oxidative stress in the pathophysiology of hypertension.氧化应激在高血压病理生理学中的作用。
Hypertens Res. 2011 Apr;34(4):431-40. doi: 10.1038/hr.2010.264. Epub 2011 Jan 13.